Linomide

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To determine whether linomide (roquinimex) is better than placebo in slowing the time to confirmed clinical worsening… (More)
Is this relevant?
2000
2000
Due to an unexpected increase in serious cardiovascular events in MS patients treated with Linomide, a synthetic immunomodulator… (More)
Is this relevant?
1997
1997
Linomide is a p.o. active antiangiogenic agent that has been demonstrated to be effective in suppressing the in vivo growth of… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
1996
1996
There are two distinct phases during prostatic carcinogenesis with regard to tumor blood vessel development. During the first or… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
In a number of experimental systems in which lymphocyte depletion was induced by apoptosis-inducing manipulations, no apoptotic… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
1995
1995
The synthetic immunomodulator Linomide, a quinoline-3-carboxamide, has a profound inhibitory influence in several experimental… (More)
Is this relevant?
1995
1995
Linomide, a quinoline-3-carboxamide, has the ability to inhibit the growth of prostatic cancer in vivo but not in vitro (T… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
  • table 5
Is this relevant?
1995
1995
Human prostatic cancer cells have a remarkably low rate of proliferation even when they have metastasized to the bone and have… (More)
Is this relevant?
1993
1993
Linomide is a synthetic immunomodulator that enhances natural killer cell activity and significantly activates several… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
1993
1993
Linomide (N-phenylmethyl-1,2-dihydro-4-hydroxyl-1-methyl-2-oxoquinoline-3-carboxa mide) has a reproducible in vivo antitumor… (More)
  • figure I
  • table 2
  • table I
  • figure 2
  • table 3
Is this relevant?